implanted. Alzet miniosmotic pumps (2ML1, ALZA Corp, Palo Alto, CA), delivering 50,400 U/kg/d of rhGM-CSF over a period of seven days, were used in these experiments.
Pumps were filled with either rhGM-CSF (n -5) or saline (n -2), and implanted between days 0 and 5. For surgical implantation of the pumps, monkeys were administered a general gas anesthesia: 0.5% to 5% halothane in a 65% N20-30% 02 mixture. Pumps were implanted subcutaneously, along the midline of the back, caudal to the scapular crests. The skin was closed with 4/0 chromic gut placed in a continuous subcuticular suture pattern and bandaged. At the end of seven days, the pump was removed through the same surgical wound, flushed with a 50:50 hydrogen peroxide-sterile water solution and Betadine, and then packed with Betadine-soaked gauze and the animal lightly bandaged. The packing was changed on a daily basis for the next few days and was continually treated until healing was complete. All pump implantation sites healed within a week. The pump site was cultured for bacteria after pump removal and all bacterial cultures were negative.
The rhGM-CSF used in these experiments was provided by Genetics Institute.
A unit of activity for rhGM-CSF has been defined as the amount of GM-CSF needed to stimulate half of the maximal possible incorporation of 3H-thymidine by CML peripheral blood myeloblasts.7
The rhGM-CSF used in these studies had an activity of either 106 or l0 U/ml. A loading dose of 50,000 U/kg was administered intravenously on the day of pump implantation. 
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